Page 1

Hologic Announces Financial Results for Third Quarter of Fiscal 2021 Revenue of $ 1.168 Billion Increases 42.0 % , 37.8 % in Constant Currency Organic Revenue Increases 38.4 % , 34.2 % in Constant Currency Company Posts GAAP Diluted EPS of $ 1.04 , Non - GAAP Diluted EPS of $ 1.33 - MARLBOROUGH , Mass .-- ( BUSINESS WIRE ) -- July 28 , 2021 -- Hologic , Inc. ( Nasdaq : HOLX ) announced today the Company's financial results for the fiscal third quarter ended June 26 , 2021 . " Hologic posted very strong financial results in our third fiscal quarter , with both revenue and EPS growth exceeding our guidance , " said Steve MacMillan , the Company's chairman , president and chief executive officer . “ Our base businesses showed strong momentum and we continued to make a big difference against the COVID pandemic . And we used our strong cash flows to strengthen the Company for the future by finalizing the Mobidiag acquisition . " Recent Highlights • Revenue increased 42.0 % for the quarter , or 37.8 % in constant currency . Excluding material acquisitions and divestitures , organic revenue in the third quarter increased 38.4 % , or 34.2 % in constant currency . • Global revenue for the Company's Breast and Skeletal Health and GYN Surgical divisions grew significantly compared to the prior year period , when sales were most negatively affected by the COVID - 19 pandemic . Notably , both divisions also grew compared to the same period in 2019 . ● ● ● Worldwide diagnostics revenue of $ 665.5 million increased 25.0 % , or 20.3 % in constant currency , despite lower demand for the Company's two COVID assays that run on the Panther® and Panther Fusion® systems . Completed the acquisition of Finnish molecular diagnostics company Mobidiag for an enterprise value of approximately $ 808 million . The American College of Obstetricians and Gynecologists updated its guidance for the management of symptomatic uterine leiomyomas to support the use of laparoscopic radiofrequency ablation . And Cigna updated its medical policy to cover the Acessa laparoscopic radiofrequency ablation procedure as medically necessary . ● • Launched Project Health Equality , which strives to address the structural and cultural barriers that prevent Black and Hispanic women in the U.S. from receiving the same quality health care as white women . Project Health Equality is a multiyear investment of more than $ 20 million to drive research , education and access to ensure women of color receive the care they want , need and deserve . Cash flow from operations was a very strong $ 662.9 million in the third quarter . In addition to closing the Mobidiag acquisition , the Company repurchased approximately 3.0 million shares of its common stock for $ 188 million in the quarter . Key financial results for the fiscal third quarter are shown in the table below . Revenues Gross Margin Operating Expenses Operating Margin Net Margin Diluted EPS Q3'21 $ 1,168.3 60.1 % $ 343.0 30.7 % 22.9 % $ 1.04 GAAP Q3'20 $ 822.9 56.6 % $ 275.1 23.2 % 16.6 % $ 0.53 Change Increase ( Decrease ) 42.0 % Exhibit 99.1 350 bps 24.7 % 750 bps 630 bps 96.2 % Q3'21 $ 1,168.3 66.1 % $ 310.1 39.5 % 29.5 % $ 1.33 Non - GAAP Q3'20 $ 822.9 64.7 % $ 261.1 33.0 % 23.7 % $ 0.75 Change Increase ( Decrease ) 42.0 % 140 bps 18.8 % 650 bps 580 bps 77.3 %